953392-00-2

Upstream product

• 351003-51-5 4-bromo-3-fluorobenzene-1-sulfonyl chloride 
• 99-09-2 3-nitro-aniline 

Downstream Products

• 953392-01-3 3-fluoro-4-(5-methyl-2-furanyl)-N-(3-nitrophenyl)benzenesulfonamide 
• 953392-40-0 N₁-[3-({[3-fluoro-4-(5-methyl-2-furanyl)phenyl]sulfonyl}amino)phenyl]-2-methylalaninamide hydrochloride 
• 953392-03-5 1,1-dimethylethyl (2-{[3-({[3-fluoro-4-(5-methyl-2-furanyl)phenyl]sulfonyl}amino)phenyl]amino}-1,1-dimethyl-2-oxoethyl)carbamate 
• 953392-02-4 N-(3-aminophenyl)-3-fluoro-4-(5-methyl-2-furanyl)benzenesulfonamide 

Relevant academic research and scientific papers

COMPOUNDS FOR THE DEGRADATION OF STK4 AND TREATMENT OF HEMATOLOGIC MALIGNANCIES

The application relates to a compound of Formula (I) which modulate the amount of STK4, a pharmaceutical composition comprising the compound, and a method of treating or preventing a disease or disorder associated with the modulation of STK4.

ARYL AND HETEROARYL SULPHONAMIDES AS GROWTH HORMONE SECRETAGOGUE RECEPTOR AGONISTS

The present invention therefore provides compounds of formula (I) or pharmaceutically acceptable salts thereof: (I) processes for their preparation, pharmaceutical compositions containing the same and to their use in the treatment of gastrointestinal and other disorders.